181 related articles for article (PubMed ID: 26272706)
1. Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.
Lee K; Lam KH; Kruel AM; Mahrhold S; Perry K; Cheng LW; Rummel A; Jin R
Toxicon; 2015 Dec; 107(Pt A):43-9. PubMed ID: 26272706
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex.
Lee K; Zhong X; Gu S; Kruel AM; Dorner MB; Perry K; Rummel A; Dong M; Jin R
Science; 2014 Jun; 344(6190):1405-10. PubMed ID: 24948737
[TBL] [Abstract][Full Text] [Related]
3. Multivalency effects of hemagglutinin component of type B botulinum neurotoxin complex on epithelial barrier disruption.
Amatsu S; Matsumura T; Yutani M; Fujinaga Y
Microbiol Immunol; 2018 Feb; 62(2):80-89. PubMed ID: 29266585
[TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxin A complex recognizes host carbohydrates through its hemagglutinin component.
Yao G; Lee K; Gu S; Lam KH; Jin R
Toxins (Basel); 2014 Feb; 6(2):624-35. PubMed ID: 24525478
[TBL] [Abstract][Full Text] [Related]
5. Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity.
Lee K; Gu S; Jin L; Le TT; Cheng LW; Strotmeier J; Kruel AM; Yao G; Perry K; Rummel A; Jin R
PLoS Pathog; 2013; 9(10):e1003690. PubMed ID: 24130488
[TBL] [Abstract][Full Text] [Related]
6. Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia.
Lam TI; Stanker LH; Lee K; Jin R; Cheng LW
Cell Microbiol; 2015 Aug; 17(8):1133-43. PubMed ID: 25640773
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Hemagglutinin Negative Botulinum Progenitor Toxins.
Kalb SR; Baudys J; Smith TJ; Smith LA; Barr JR
Toxins (Basel); 2017 Jun; 9(6):. PubMed ID: 28617306
[TBL] [Abstract][Full Text] [Related]
8. Functional Analysis of Botulinum Hemagglutinin (HA).
Matsumura T; Fujinaga Y
Methods Mol Biol; 2020; 2132():191-200. PubMed ID: 32306328
[TBL] [Abstract][Full Text] [Related]
9. A novel neurotoxoid vaccine prevents mucosal botulism.
Kobayashi R; Kohda T; Kataoka K; Ihara H; Kozaki S; Pascual DW; Staats HF; Kiyono H; McGhee JR; Fujihashi K
J Immunol; 2005 Feb; 174(4):2190-5. PubMed ID: 15699151
[TBL] [Abstract][Full Text] [Related]
10. The long journey of botulinum neurotoxins into the synapse.
Rummel A
Toxicon; 2015 Dec; 107(Pt A):9-24. PubMed ID: 26363288
[TBL] [Abstract][Full Text] [Related]
11. Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.
Sugawara Y; Yutani M; Amatsu S; Matsumura T; Fujinaga Y
PLoS One; 2014; 9(10):e111170. PubMed ID: 25340348
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C.
Jin Y; Takegahara Y; Sugawara Y; Matsumura T; Fujinaga Y
Microbiology (Reading); 2009 Jan; 155(Pt 1):35-45. PubMed ID: 19118344
[TBL] [Abstract][Full Text] [Related]
13. Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.
Kumaran D; Adler M; Levit M; Krebs M; Sweeney R; Swaminathan S
Bioorg Med Chem; 2015 Nov; 23(22):7264-73. PubMed ID: 26522088
[TBL] [Abstract][Full Text] [Related]
14. Botulinum Hemagglutinin: Critical Protein for Adhesion and Absorption of Neurotoxin Complex in Host Intestine.
Amatsu S; Fujinaga Y
Methods Mol Biol; 2020; 2132():183-190. PubMed ID: 32306327
[TBL] [Abstract][Full Text] [Related]
15. A novel function of botulinum toxin-associated proteins: HA proteins disrupt intestinal epithelial barrier to increase toxin absorption.
Fujinaga Y; Matsumura T; Jin Y; Takegahara Y; Sugawara Y
Toxicon; 2009 Oct; 54(5):583-6. PubMed ID: 19073205
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of intestinal absorption of botulinum neurotoxin complex].
Matsumura T
Nihon Saikingaku Zasshi; 2019; 74(3):167-175. PubMed ID: 31787706
[TBL] [Abstract][Full Text] [Related]
17. Role of nontoxic components of serotype D botulinum toxin complex in permeation through a Caco-2 cell monolayer, a model for intestinal epithelium.
Niwa K; Koyama K; Inoue S; Suzuki T; Hasegawa K; Watanabe T; Ikeda T; Ohyama T
FEMS Immunol Med Microbiol; 2007 Apr; 49(3):346-52. PubMed ID: 17378898
[TBL] [Abstract][Full Text] [Related]
18. Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry.
Kalb SR; Baudys J; Barr JR
BMC Microbiol; 2015 Oct; 15():227. PubMed ID: 26494251
[TBL] [Abstract][Full Text] [Related]
19. High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex.
Lee K; Lam KH; Kruel AM; Perry K; Rummel A; Jin R
Biochem Biophys Res Commun; 2014 Apr; 446(2):568-73. PubMed ID: 24631690
[TBL] [Abstract][Full Text] [Related]
20. The botulinum toxin complex meets E-cadherin on the way to its destination.
Sugawara Y; Fujinaga Y
Cell Adh Migr; 2011; 5(1):34-6. PubMed ID: 20935473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
